Deep dives on Northern European mid-caps seeking non-consensus ideas and targeting 20%+ CAGR. Private investor with Nordic roots. Independent and long-term perspective.
Chemist and biocatalysis scientist, curious about the broader conversation between science and society: how we make sense of knowledge, and how it influences culture, and everyday choices.